Iterum Therapeutics Plc (ITRM) Tops Q2 EPS by 15c
Tweet
Share
E-mailGet Alerts ITRM Hot Sheet
Join SI Premium – FREE
Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q2 EPS of ($0.30), $0.15 better than the analyst estimate of ($0.45).
For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oppenheimer Starts Viatris (VTRS) at Outperform
- Increasing unusual call option volume: NICE GFL GLAS NRG PLNT XRT CYPH GLBE
- Oppenheimer Starts ANI Pharmaceuticals (ANIP) at Perform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
